(Q44506162)

3 December 2017

Effect of glutamine on glutathione, IGF-I, and TGF-beta 1. (English)

1 reference

3 December 2017

Anita T Johnson

1

1 reference

3 December 2017

Yihong Cao Kaufmann

2

1 reference

3 December 2017

Shaoke Luo

3

1 reference

3 December 2017

Valentina Todorova

4

1 reference

3 December 2017

V Suzanne Klimberg

5

1 reference

3 December 2017

1 May 2003

1 reference

Journal of Surgical Research

3 December 2017

1 reference

3 December 2017

111

1 reference

3 December 2017

2

1 reference

3 December 2017

222-228

1 reference

Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Insulin-like growth factors and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

DNA binding and adduct formation of 7,12-dimethylbenz[a]-anthracene by rat mammary epithelial cell aggregates in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Glutamine suppresses PGE2 synthesis and breast cancer growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Effect of 7,12-dimethylbenz[a]anthracene (DMBA) on gut glutathione metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Free insulin-like growth factor-I and breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

IGF-I: a mitogen also involved in differentiation processes in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Serum levels of transforming growth factor beta1 in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

Serum insulin-like growth factor-I and breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900083-0

10.1016/S0022-4804(03)00083-0

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/titcmoihmncoxfcfeog3mwsb7u

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_titcmoihmncoxfcfeog3mwsb7u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/titcmoihmncoxfcfeog3mwsb7u

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/titcmoihmncoxfcfeog3mwsb7u